The FDA has approved Gilead's once-daily HIV pill, Bixlenvo, designed to simplify treatment for patients with controlled virus and streamline complex regimens.
Before discounts or rebates, a 30-day supply of Bixlenvo costs $4,595
Aug 28, 2026
12:34 pm
What's the storyThe US Food and Drug Administration (FDA) has approved a new once-daily HIV pill from Gilead Sciences.
The drug, called Bixlenvo, is designed to simplify treatment for patients whose virus is already under control but are on complicated regimens.
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
FDA approves Gilead's Bixlenvo HIV pill for complex regimens
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens
FDA approves smallest single-pill HIV regimen, Bixlenvo
Gilead gets another HIV treatment approval, extending lenacapavir's dominance
Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet
Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV
